France-based Qubit Pharmaceuticals was founded in 2020 with the vision of becoming a world leader in quantum-assisted drug development. Its software makes the most of existing and emerging supercomputers to model quantum effects at the microscopic level with high precision. The company aims to work alongside pharmaceutical and biotechnology companies to reduce the cost and […]

View post to subscribe to site newsletter.

UK-based Mestag Therapeutics was established in 2020 to develop new medicines for people affected by inflammatory disease and cancer, based on insights into disease-driving fibroblast subpopulations. Fibroblasts are a type of cell present in many different tissues in the body; recent data point to them as being important drivers of disease. Historically, fibroblasts were thought […]

View post to subscribe to site newsletter.

Cardea Bio is developing biology-based transistors for linking biology directly up to computers. These transistors leverage graphene and are designed to replace optical static observations with interactive live-streams of multi-omics signal analysis, representing a new life science observation paradigm according to the company, where multi-omics data-streams will be the new norm instead of most of […]

View post to subscribe to site newsletter.